These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 22943930

  • 21. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
    Suzuki F, Toyoda J, Katano Y, Sata M, Moriyama M, Imazeki F, Kage M, Seriu T, Omata M, Kumada H.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238
    [Abstract] [Full Text] [Related]

  • 22. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [Abstract] [Full Text] [Related]

  • 23. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J, Ryzlová M, Striteský J, Horák J.
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.
    Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L, Gray DF.
    Hepatology; 1999 Mar; 29(3):889-96. PubMed ID: 10051494
    [Abstract] [Full Text] [Related]

  • 25. Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
    Hasanjani Roushan MR, Hajiahmadi M, Shafaie S.
    Int J Clin Pract; 2005 Jul; 59(7):791-4. PubMed ID: 15963206
    [Abstract] [Full Text] [Related]

  • 26. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
    Pockros PJ, Schiff ER, Shiffman ML, McHutchison JG, Gish RG, Afdhal NH, Makhviladze M, Huyghe M, Hecht D, Oltersdorf T, Shapiro DA.
    Hepatology; 2007 Aug; 46(2):324-9. PubMed ID: 17654603
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis.
    Suda I, Ishikawa F, Hatakeyama M, Miyawaki M, Kudo T, Hirano K, Ito A, Yamakawa O, Horiuchi S.
    Eur J Clin Nutr; 2008 Jan; 62(1):60-7. PubMed ID: 17299464
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks].
    He H, Xu ZN, Cai DC, Nai N, Ling N, Zeng WQ, Shi XF, Zhao YR, Zhou Z, Zhang DZ.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):271-4. PubMed ID: 19403025
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.